Roy de Souza

Last updated
Roy de Souza
Born1970 (age 53–54)
Nairobi, Kenya
NationalityIndian
Education University of Oxford (M.S. in Engineering)
Kellogg Business School (M.B.A.)
OccupationEngineer
Known forCancer research (AI Drug Discovery Per Patient)
Spouse
​
​
(m. 2008;died 2020)​
Children3
Parent
Relatives

Roy de Souza (born 1970) is an Indian engineer and writer. He is the co-founder of technology company ZEDO and medical technology company BreakBio. [1] [2] In 2022, he was a TEDx speaker. [3] In May of 2023 he and his late wife were honored by the American Cancer Society for Roy's work in personalized medicine. [4]

Contents

Education

He earned a master's degree in engineering from the University of Oxford and an MBA from Kellogg Business School. [1]

Career

De Souza served as a strategy consultant at the COBA Group, a strategy consulting boutique based in the UK. [5] [6]

De Souza also worked in product management for the Elon Musk-founded web software company Zip2. [7]

De Souza founded technology company ZEDO in 1999. [1] [8] In 2006, he founded the company Zebo, an offshoot of ZEDO focused on allowing users to catalog personal possessions and shop for similar items. [9] [10] [11] De Souza launched online ad exchange ZINC India in 2011, which was originally ZEDO's ad exchange platform in India before becoming a separate company. [12] [13] [14] He served as the ZEDO's CEO and oversaw the company as it transitioned into a subsidiary of Discovery following its acquisition by Discovery, Inc. in 2021. [15] [16] [17]

In 2022, he was a TEDx speaker, talking about vaccines to prevent cancer. . [3]

Cancer research

After his wife, Aisha de Sequeira's cancer diagnosis, de Souza became involved in vaccine research to develop a personalized vaccine for her cancer. [1] De Souza went on to co-found medical technology company BreakBio, basing the company in Boston, Massachusetts. [1] [2] [18] BreakBio develops personalized vaccines [2] and AI software that aids cancer treatments by identifying that difference between normal cells and cancer cells. [19] De Souza and Devabhaktuni Srikrishna also co-authored the book Cancer: What a Personal Crisis Taught Us About How T-Cells Can Save Your Life. [20]

Bibliography

Related Research Articles

<span class="mw-page-title-main">AstraZeneca</span> British pharmaceutical company

AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">George Church (geneticist)</span> American geneticist

George McDonald Church is an American geneticist, molecular engineer, chemist, serial entrepreneur, and pioneer in personal genomics and synthetic biology. He is the Robert Winthrop Professor of Genetics at Harvard Medical School, Professor of Health Sciences and Technology at Harvard University and Massachusetts Institute of Technology, and a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Advaxis Inc. is an American company devoted to the discovery, development and commercialization of immunotherapies based on a technology platform which uses engineered Listeria monocytogenes. The company is headquartered in Princeton, New Jersey and was incorporated in Delaware in 2006.

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants desugned for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

<span class="mw-page-title-main">Thermo Fisher Scientific</span> Provisioner of scientific consumables, equipment, and services

Thermo Fisher Scientific Inc. is an American-headquartered life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).

Zedo is a US and India-based advertising technology company that provides several online advertising products and services to Internet publishers, advertisers, and agencies. The company was founded in 1999 by Roy de Souza.

CancerVax was an American pharmaceutical company founded in 1998 by Donald Morton. The company sought to develop a vaccine for cancer, and had candidates for melanoma reach phase III clinical trials. When those trials proved unsuccessful in 2005, the company soon underwent a reverse takeover with Micromet.

<span class="mw-page-title-main">Avax Technologies</span> American biotechnology company

Avax Technologies, Inc. is a Philadelphia-based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007. In previous studies, MVax demonstrated a 5-year overall survival rate (OS)of 44% and response rate of 35%.

Biovest International, Inc was a Minneapolis-based biotechnology company. Their active immunotherapy, BiovaxID, is a cancer vaccine whose first indication was intended to be consolidation/adjuvant therapy of follicular Non-Hodgkin's Lymphoma. Biovest filed to reorganize under chapter 11 bankruptcy in 2014, BiovaxID was refused European marketing authorization in 2015, and Biovest's stock listing was revoked in 2017.

<span class="mw-page-title-main">Moderna</span> American biotechnology company

Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

<span class="mw-page-title-main">Jason Fernandes</span> Indian blockchain entrepreneur

Jason Fernandes is Web3 entrepreneur, Investor, and technology columnist hailing from Goa. Fernandes is the co-founder of AdLunam Inc.a Web3 investment platform. As a teenager, Fernandes founded the internet portal ZeoCities.com, the non-profit LDKids.org and wrote for CHIP Magazine. Later, while studying at the University of Texas, Austin, Fernandes co-invented the Internet-based DVR, InstantTV, and was part of the founding team at PerceptiveI. Fernandes was a monthly technology columnist for GlobeAsia Magazine, Indonesia for 5 years producing over 60 columns over this period. Fernandes is often quoted in Web3 publications and has spoken at TEDx events.

Individualized cancer immunotherapy, also referred to as individualized immuno-oncology, is a novel concept for therapeutic cancer vaccines that are truly personalized to a single individual.

Edward Francis Fritsch is a scientist in the field of molecular biology and cancer immunology.

<span class="mw-page-title-main">BioNTech</span> German biotechnology company

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger ribonucleic acid (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer.

<span class="mw-page-title-main">Uğur Şahin</span> German oncologist and immunologist (born 1965)

Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.

<span class="mw-page-title-main">Özlem Türeci</span> German physician, scientist and entrepreneur

Özlem Türeci is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief medical officer since 2018. Since 2021, she has been Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. Türeci and her spouse, Uğur Şahin, have won a number of awards.

<span class="mw-page-title-main">Aisha de Sequeira</span> Indian banker (1969–2020)

Julia Maria Aisha de Sequeira was an Indian banker. She was the co-head of Morgan Stanley India from 2013 through 2020. In 2007, she became the founding head of investment banking for Morgan Stanley India, and continued in this position until her death in 2020.

<span class="mw-page-title-main">Acuitas Therapeutics</span> Canadian biotechnology company

Acuitas Therapeutics Inc. is a Canadian biotechnology company based in Vancouver, British Columbia. The company was established in February 2009 to specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticle (LNP) technology, a key component of the mRNA vaccines deployed for COVID-19.

References

  1. 1 2 3 4 5 "Meet Roy de Souza, the tech entrepreneur who turned personal crisis into war against cancer". Moneycontrol. 20 June 2019.
  2. 1 2 3 "How A Tech Entrepreneur Turned a Personal Crisis Into A War Against Cancer". YPO. August 13, 2019.
  3. 1 2 "Home". TEDx2022.
  4. ↑ http://womenandwellness.com
  5. ↑ "Goan Voice UK: supplement on Royde Souza". www.goanvoice.org.uk.
  6. ↑ https://nulta.net/2019/03/car-t-cells-new-hope-for-cancer-therapy/
  7. ↑ Otlacan, Otilia (July 12, 2011). "Interview: Zedo CEO Roy de Souza Discusses Ad Exchanges in the Current Marketplace". Ad Tech Daily.
  8. ↑ "Customer Success Stories: Case Studies, Videos, Podcasts, Innovator stories". Amazon Web Services, Inc.
  9. ↑ Staff Writer. "Got Roomfuls of Stuff? Now Sites Will Help Keep Track of It". Gainesville Sun.
  10. ↑ Rosenbloom, Stephanie (September 17, 2006). "A Sense of Belonging Among Belongings". The New York Times– via NYTimes.com.
  11. ↑ "If We Build It, We Will Come: Unleash the Power of Crowds in Your Business | Zebo.com | InformIT". www.informit.com.
  12. ↑ "Zedo founder launches online exchange". www.ciol.com. 6 October 2011.
  13. ↑ "Zedo To Spin Off Online Ad Exchange Platform Zinc In India". Techcircle. October 14, 2011.
  14. ↑ Saxena, Anupam (October 17, 2011). "Updated: Zedo To Spin-Off Indian Unit; Not To Form JV With Ad Agency".
  15. ↑ "Discovery, Inc acquires assets of ZEDO".
  16. ↑ "Discovery, Inc. acquires assets of ad-tech co ZEDO". www.thehindubusinessline.com. December 8, 2021.
  17. ↑ "Discovery acquires Zedo's assets". Campaign India.
  18. ↑ Krishnan, Revathi (December 11, 2020). "Aisha de Sequeira — 'daughter of Goa' & Morgan Stanley India co-head who idolised Steve Jobs".
  19. ↑ "BreakBio". forcefamilyoffice.org.
  20. ↑ De Souza, R. & Srikrishna, D. (2019). Cancer: What a personal crisis taught us about how T-cells can save your life. BreakBio Corp. ISBN   9780578548777
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.